We further investigated the expression of IL7R in ovarian cancer cells and found that IL7R levels were significantly upregulated in malignant tissues compared with those in benign ovarian tumors, with staining mainly localized in tumor cells (Fig. 1C; clinicopathological details are provided in Supplementary Table S1). This evidence concerns the gene IL7R and ovarian benign neoplasm.